Skip to main content
Premium Trial:

Request an Annual Quote

New Center to Integrate 'Omics into Immune System Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — The Immune Tolerance Institute and the David H. Murdock Research Institute have established a Kannapolis, NC, research center designed to speed up discovery and development of treatments for people with a broad range of immune system-related conditions.

The Center for Critical Path Research in Immunology will operate at the Murdock Institute's facility within the North Carolina Research Campus, a $1.5 billion, 350-acre laboratory/office site developed by Murdock — a real estate and food magnate who is chairman of Dole Foods — to accommodate health, nutrition, and agricultural research.

CCPRI said in a statement that it will integrate "genomic, cellular, proteomic and bioinformatics technology platforms to discover and develop novel biomarkers," as well as "match patients with therapies that will provide them the greatest benefit."

The new research center said its goals are "to accelerate the translation of basic discoveries into medical practice, and to become a major resource for a range of academic and industry partners."

Based in Menlo Park, Calif., ITI is a non-profit corporation founded in partnership with the University of California, San Francisco, to translate scientific discoveries into new therapies for diseases related to the human immune system — including autoimmune diseases, allergy, asthma, cancer, and cardiovascular and infectious diseases.

The announcement of CCPRI, made earlier today, is the second in consecutive days concerning new users for the North Carolina Research Campus. Yesterday, the campus announced that General Mills will establish a presence there to carry out research into whole grains and vegetables.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.